NCT06935097
Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer
Enrolling by Invitation
NAAges 18+InterventionalBasic scienceM.D. Anderson Cancer CenterInvestigator-initiated
~25 participants
Updated 2026-05-22 on ClinicalTrials.gov
What's tested:Mediterranean diet-based Intervention
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Safety and Adverse Events (AEs)
Measured over Through study completion; an average of 1 year
Conditions
Where it's being run
1 sites across 1 statesTexas1
Study leadership
- Justin Gregg, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Histologically confirmed adenocarcinoma of the prostate that is localized based on metastatic workup ordered by the treating physician (which may include CT scan, bone scan, MRI and/or other imaging). Note that metastatic workup is not required for enrollment.
Diagnosis within 12 months prior to enrollment OR
Currently managed on active surveillance, with initial biopsy being \<5 years from date of enrollment
Self-identified Hispanic and/or Black/African American
Patient at LBJ Hospital
Exclusion
Special dietary requirements such that patient is unwilling to attempt dietary change
Unwillingness to participate in study activities
Inability to keep appointments
Food allergy prohibitive of a Mediterranean diet, i.e. nuts allergy
What this trial measures
- Safety and Adverse Events (AEs)Through study completion; an average of 1 year
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0